Skip to main content

Table 1 Sociodemographic and clinical characteristics of the cohort during the 5-years of follow-up

From: Predictive factors over time of health-related quality of life in COPD patients

Variable

Unit/Category

Baseline

n = 543

1-year

n = 480 (88%)

2-years

n = 428 (79%)

5-year

n = 324 (60%)

SGRQ

Symptoms

44.5 (22.2)

42.5 (22.4)

43.1 (23.5)

44.1 (23.4)

Activity

48.7 (24.9)

45.9 (25.0)

46.6 (25.0)

47.4 (25.4)

Impacts

32.0 (20.9)

30.4 (21.1)

30.1 (20.4)

30.4 (20.9)

Sex

M

522 (96.1)

459 (95.6)

408 (95.3)

308 (95.1)

F

21 (3.9)

21 (4.4)

20 (4.7)

16 (4.9)

Age

Years

68.3 (8.3)

67.6 (8.4)

67.4 (8.3)

66.2 (8.4)

BMI

 

28.3 (4.4)

28.3 (5.2)

28.1 (4.4)

27.6 (4.8)

Dyspnea (mMRC)

0

69 (12.7)

85 (17.7)

75 (17.5)

57 (17.6)

1

264 (48.6)

248 (51.7)

188 (43.9)

134 (41.4)

2

166 (30.6)

127 (26.5)

142 (33.2)

100 (30.9)

3–4

44 (8.1)

20 (4.3)

23 (5.4)

33 (10.2)

FEV1

ml

1465(441)

1470(501)

1513(470)

1391(451)

FEV1%

Percentage

55.0 (13.3)

55.2 (16.0)

57.2 (14.7)

54.3 (14.8)

< 30

18 (3.3)

22 (4.6)

13 (3.0)

14 (4.3)

30–50

167 (30.8)

131 (27.3)

111 (25.9)

118 (36.4)

≥50

358 (65.9)

327 (68.1)

304 (71.0)

192 (59.3)

RV%

Percentage

159 (46.9)

158 (47.7)

158 (50.4)

161 (48.4)

DLCO%

Percentage

71.5 (23.5)

75.6 (26.6)

76.7 (26.9)

68.1 (21.9)

Smoking habit/status

Pack/year

46.8(27.3)

46.3(26.4)

46.5(26.0)

46.8(25.9)

Smoker

114 (23.0)

91 (19.0)

79 (18.5)

58 (17.9)

Former smoker

414 (76.2)

375 (78.1)

338 (79.0)

256 (79.0)

Non smoker

15 (2.8)

14 (2.9)

11 (2.6)

10 (3.1)

6mWT

Meters

409 (92)

421 (118)

412 (116)

397 (123)

PA

< 2 h/week

48 (8.8)

44 (9.2)

48 (11.2)

62 (19.1)

2–4 h/week

110 (20.3)

103 (21.5)

94 (22.0)

60 (18.5)

> 4 h/weeka

219 (40.3)

203 (42.3)

165 (38.6)

117 (36.1)

Work/intense

166 (30.6)

130 (27.1)

121 (28.3)

85 (26.2)

CCI

Points

2.41(1.42)

2.46(1.42)

2.47(1.41)

2.55(1.35)

< 2

172 (31.7)

145 (30.2)

130 (30.4)

87 (26.9)

2–3

264 (48.6)

233 (48.5)

208 (48.6)

159 (48.8)

> 3

107 (19.7)

102 (21.3)

90 (21.0)

79 (24.4)

Strength

Handgrip (kg)

34.1 (9.4)

33.7(10.2)

33.0 (9.6)

32.9(10.4)

Previous hospitalizations

0

427 (78.6)

406 (84.6)

377 (88.1)

234 (72.2)

1

80 (14.7)

51 (10.6)

30 (7.0)

40 (12.4)

2

16 (3.0)

14 (2.9)

16 (3.7)

23 (7.1)

3

9 (1.7)

6 (1.3)

4 (0.9)

14 (4.3)

> 3

11 (2.0)

3 (0.6)

1 (0.2)

13 (4.0)

Treatment b

0–1

73 (13.4)

57 (11.9)

48 (11.2)

36 (11.1)

2

121 (22.2)

91 (19.0)

87 (20.3)

56 (17.3)

3

349 (64.3)

330 (68.8)

293 (68.5)

232 (71.6)

  1. Frequencies and percentages by category for categorical variables, and mean and standard deviation for continuous variables are shown
  2. BMI body mass index, CCI Charlson comorbidity index, DLCO carbon monoxide diffusing capacity, Dyspnea mMRC Medical research council scale, FEV1 forced expiratory volume in the first second, PA physical activity, RV residual volume, 6mWT 6-min walking test
  3. a Gardening subjects were included in this category
  4. b Treatment has been classified as follows: 0–1 out of LABA/LAMA; 2 out of LABA/LAMA/ICS; 3 of them LABA+LAMA+ICS